LENZ plans NDA sub­mis­sion for pres­by­opia eye drops this year, looks to launch in 2025

LENZ Ther­a­peu­tics plans to seek FDA ap­proval for its in­ves­ti­ga­tion­al eye drops for pres­by­opia, set­ting up the drug to com­pete against Ab­b­Vie’s Vuity and Ora­sis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER